Consumer Durables Healthcare Sector

Ocular Therapeutix

Market Cap: US$1.2b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

AdaptHealth

Market Cap: US$1.2b

Distributes home medical equipment (HME), medical supplies, and home and related services in the United States.

ANI Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Pediatrix Medical Group

Market Cap: US$1.1b

Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

Kestra Medical Technologies

Market Cap: US$1.1b

Operates as a wearable medical device and digital healthcare company.

Pulse Biosciences

Market Cap: US$1.1b

Operates as a novel bioelectric medicine company.

Natus Medical

Market Cap: US$1.1b

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.

U.S. Physical Therapy

Market Cap: US$1.1b

Operates and manages outpatient physical therapy clinics.

Viridian Therapeutics

Market Cap: US$1.1b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

Establishment Labs Holdings

Market Cap: US$1.1b

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

Neuren Pharmaceuticals

Market Cap: AU$1.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Spire Healthcare Group

Market Cap: UK£769.3m

Owns and operates private hospitals and clinics in the United Kingdom.

Mineralys Therapeutics

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

Aveanna Healthcare Holdings

Market Cap: US$1.0b

A diversified home care platform company, provides pediatric and adult healthcare services in the United States.

BioLife Solutions

Market Cap: US$1.0b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

10x Genomics

Market Cap: US$1.0b

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

OPKO Health

Market Cap: US$999.2m

A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

Oculis Holding

Market Cap: US$989.7m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

Craneware

Market Cap: UK£724.9m

Develops, licenses, and supports computer software for the healthcare industry in the United States.

MiMedx Group

Market Cap: US$979.3m

Develops and distributes placental tissue allografts for various sectors of healthcare.

Pennant Group

Market Cap: US$957.2m

Provides healthcare services in the United States.

Integra LifeSciences Holdings

Market Cap: US$955.9m

Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

Arcus Biosciences

Market Cap: US$955.1m

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

NeoGenomics

Market Cap: US$953.6m

Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

Harrow

Market Cap: US$950.5m

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

Ardelyx

Market Cap: US$949.8m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Intellia Therapeutics

Market Cap: US$948.8m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

CareDx

Market Cap: US$943.8m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

Phibro Animal Health

Market Cap: US$942.0m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

Collegium Pharmaceutical

Market Cap: US$927.6m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

STAAR Surgical

Market Cap: US$924.8m

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

Geron

Market Cap: US$923.5m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

CureVac

Market Cap: US$920.9m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

agilon health

Market Cap: US$919.0m

Provides healthcare services for seniors through primary care physicians in the communities of the United States.